Christina Rose highlights the landmark ROSE study, in this July Trial of the Week.

Stephanie Bass returns to review the management of HRS, focusing on HRS-AKI, then discussing the novel vasopressor, terlipressin.

Jason Roberts (Pharmacist and study author) joins from Australia to highlight the recently published “Continuous v. Intermittent Beta-Lactam Antibiotic Infusions in Critically Ill Patients with Sepsis,” the BLING III study.

Scott Dietrich, Brian Gilbert, and Todd Miano join to help review the ANNEXa-I trial, focusing on the safety/thrombotic outcomes and practical application/considerations in Part 2 of this 2-part episode series.

Brian Gilbert, Scott Dietrich, and Todd Miano review the ANNEXa-I study focusing on efficacy and statistics in Part 1 of this 2-part episode series.

Nick Tran and Haley Torr join to help highlight the most notable articles from January 2024 in this Literature Review Series episode.

Paul Szumita highlights the landmark 2012 PROWESS-SHOCK study, in this June Trial of the Week.

Jac Crawford and Kate Hartman join to help highlight the 16 most notable articles from 2023 in this Year-In-Review Literature Review Series episode.

Justin Lin highlights his research study, Efficacy of Ketamine for Acute Agitation in the Emergency Department, in this May Trial of the Week.

Doug Black, Pharmacist contributing editor to the Sanford Guide, joins to take a deep dive into this tremendous infectious diseases resource.

Gabe Fontaine joins to highlight Code ICH, a new bundle-based approach for ICH patients.

John Devlin highlights the MENDS2 study in this May Trial of the Week.

Nick reviews the recently released ANNEXA-I study, researching andexanet alfa use in ICH patients, for this rapid reaction episode.

Jim Miller highlights the DESIRE study as a Trial of the Week, before Michael Liu highlights his experience and advice with in-flight medical emergencies.

Jenna Self and Hannah Millard help highlight some of the best and most notable articles published in December 2023.

Snehal Bhatt helps review EMPACT-MI and ULTIMATE-DAPT in Part 2 of the 2-part ACC 2024 rapid reaction episode series.

Ryan Caputo joins me to highlight 2 of the most practice-changing research studies, DanGer Shock and REDUCE-AMI, published during ACC 2024 in Part 1 of the 2-part rapid reaction episode series.

Kevin Kaucher, Angela Slampak-Cindric, and Christine Groth join me to help highlight the 2024 SCCM RSI guidelines and share their insight as panel members.

Ashley McCormick highlights the ESETT study in this April Trial of the Week.

Lauren Igneri and I debate “Thrombolytic Dosing in PE,” as part of the Versus series.

Katherine Spezzano highlights the SEPSISPAM study in this April Trial of the Week.

Judi Jacobi and Michael Sirimaturos, 2 Pharmacist panel members, review the 2024 SCCM Glycemic Control for Critically Ill Children and Adult Guidelines.

Brock Townsend and Arjay Mendoza join me to highlight some of the most pertinent articles and research published in November 2023.

Jessica Casey discusses the April Trial of the Week, SOAP II.

Salia Farrokh joins to highlight two landmark articles researching the use of nimoodipine in aneurysmal subarachnoid hemorrhage.